Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1996-11-26
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0369-4739
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
44
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
317-9
|
| pubmed:dateRevised |
2011-7-27
|
| pubmed:meshHeading |
pubmed-meshheading:8926403-Adenocarcinoma,
pubmed-meshheading:8926403-Carcinoma, Large Cell,
pubmed-meshheading:8926403-Carcinoma, Squamous Cell,
pubmed-meshheading:8926403-Chemotherapy, Adjuvant,
pubmed-meshheading:8926403-Humans,
pubmed-meshheading:8926403-Lung Neoplasms,
pubmed-meshheading:8926403-Radiotherapy, Adjuvant,
pubmed-meshheading:8926403-Survival Rate
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
[Evaluation of neo-adjuvant therapy (NAT) applied to clinical stage III of lung cancer at our center].
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|